Which of the following is a bacteriostatic antitubercular drug ?
The core concept here is understanding the pharmacological classification of antitubercular drugs. Bactericidal drugs kill the bacteria, while bacteriostatic ones inhibit their growth.
Now, the main first-line drugs for TB are isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin. Among these, I remember that isoniazid and rifampin are considered bactericidal, especially against actively multiplying bacteria. Pyrazinamide is bactericidal in acidic environments, like in macrophages. Ethambutol is bacteriostatic. Streptomycin is also bactericidal but is an aminoglycoside.
So the correct answer should be ethambutol. Let me check the options again. The user didn't list the options, but assuming that one of them is ethambutol, which is the standard bacteriostatic drug in the first-line regimen. The other options would be the bactericidal ones.
Wait, but sometimes there's confusion between bacteriostatic and bactericidal. For example, pyrazinamide's effect is more complex. It's considered bactericidal in acidic conditions but maybe not in others. However, ethambutol is consistently bacteriostatic. So if the options include ethambutol (option C, for example), that's the correct answer.
The incorrect options would be the others: isoniazid, rifampin, pyrazinamide, or streptomycin, which are all bactericidal. The clinical pearl here is that ethambutol is the only first-line anti-TB drug that's bacteriostatic. Students often mix up the classification, so remembering that ethambutol is the exception helps.
**Core Concept**
Antitubercular drugs are classified as bactericidal (kill Mycobacterium tuberculosis) or bacteriostatic (inhibit bacterial growth). Bacteriostatic agents prevent replication but require the immune system to clear the infection. Ethambutol is the only first-line antitubercular drug with bacteriostatic activity.
**Why the Correct Answer is Right**
Ethambutol inhibits arabinosyltransferases, enzymes required for mycobacterial cell wall synthesis. It lacks bactericidal activity and only arrests bacterial growth. This makes it bacteriostatic, though it is often used in combination with bactericidal drugs to prevent resistance. Its mechanism is distinct from isoniazid (inhibits cell wall mycolic acid synthesis) or rifampin (inhibits RNA polymerase), which are bactericidal.
**Why Each Wrong Option is Incorrect**
**Option A:** Isoniazid is bactericidal, targeting actively replicating M. tuberculosis by inhibiting mycolic acid synthesis.
**Option B:** Rifampin is bactericidal, acting as a potent RNA polymerase inhibitor.
**Option D:** Pyrazinamide is bactericidal in acidic environments (e.g., within macrophages), though less effective at neutral pH.
**Clinical